NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,795,845 | -67.0% | 2,092,622 | -15.2% | 0.00% | -60.0% |
| Q2 2023 | $102,365,311 | -38.6% | 2,466,634 | -11.0% | 0.01% | -44.4% |
| Q1 2023 | $166,622,782 | -49.2% | 2,770,608 | -38.1% | 0.01% | -10.0% |
| Q4 2022 | $328,263,256 | +64.6% | 4,475,300 | +70.5% | 0.01% | -23.1% |
| Q3 2022 | $199,435,000 | +25.4% | 2,624,838 | +14.7% | 0.01% | +30.0% |
| Q2 2022 | $159,057,000 | -23.2% | 2,288,595 | -8.4% | 0.01% | 0.0% |
| Q1 2022 | $207,006,000 | +10.7% | 2,498,569 | +0.4% | 0.01% | +11.1% |
| Q4 2021 | $186,934,000 | -27.0% | 2,489,794 | +13.0% | 0.01% | -35.7% |
| Q3 2021 | $255,986,000 | -48.7% | 2,203,547 | -2.0% | 0.01% | -46.2% |
| Q2 2021 | $498,781,000 | +84.3% | 2,248,585 | +9.8% | 0.03% | +62.5% |
| Q1 2021 | $270,691,000 | -19.1% | 2,047,896 | +5.9% | 0.02% | -20.0% |
| Q4 2020 | $334,777,000 | +161.1% | 1,934,681 | +68.0% | 0.02% | +122.2% |
| Q3 2020 | $128,205,000 | +98.9% | 1,151,780 | +5.9% | 0.01% | +80.0% |
| Q2 2020 | $64,472,000 | -45.1% | 1,087,223 | -37.6% | 0.01% | -50.0% |
| Q1 2020 | $117,346,000 | -16.5% | 1,742,591 | +4.4% | 0.01% | 0.0% |
| Q4 2019 | $140,614,000 | +16.4% | 1,668,610 | +3.3% | 0.01% | +11.1% |
| Q3 2019 | $120,808,000 | +21.6% | 1,615,508 | +2.8% | 0.01% | +28.6% |
| Q2 2019 | $99,320,000 | +52.9% | 1,570,771 | +16.5% | 0.01% | +40.0% |
| Q1 2019 | $64,964,000 | +51.0% | 1,348,637 | +4.9% | 0.01% | +25.0% |
| Q4 2018 | $43,027,000 | -39.0% | 1,285,146 | -4.5% | 0.00% | -20.0% |
| Q3 2018 | $70,549,000 | +70.5% | 1,346,384 | +1.9% | 0.01% | +66.7% |
| Q2 2018 | $41,369,000 | +70.9% | 1,321,727 | +19.1% | 0.00% | +50.0% |
| Q1 2018 | $24,201,000 | +5.8% | 1,110,214 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $22,864,000 | +6.7% | 1,131,968 | +4.9% | 0.00% | 0.0% |
| Q3 2017 | $21,425,000 | +14.4% | 1,079,228 | -0.3% | 0.00% | 0.0% |
| Q2 2017 | $18,728,000 | +149.9% | 1,082,589 | +17.0% | 0.00% | +100.0% |
| Q1 2017 | $7,494,000 | +11.0% | 924,947 | +7.5% | 0.00% | 0.0% |
| Q4 2016 | $6,750,000 | -8.5% | 860,129 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $7,377,000 | -19.1% | 863,764 | +10.6% | 0.00% | 0.0% |
| Q2 2016 | $9,117,000 | +414.2% | 781,171 | +537.5% | 0.00% | – |
| Q1 2016 | $1,773,000 | -9.0% | 122,539 | +40.5% | 0.00% | – |
| Q4 2015 | $1,949,000 | – | 87,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |